Rubix LS

Rubix LS is a life sciences research and development company founded in 2016 and based in Lawrence, Massachusetts. The company focuses on health equity by conducting real-world evidence studies, clinical trials, and data-driven solutions aimed at underserved and minority populations, particularly in areas like infectious diseases, rare diseases, and cancers. Founded by Reginald Swift, PhD, Rubix LS aims to address disparities in health outcomes through a comprehensive approach that integrates various data types to design inclusive therapies and clinical trials.

The company operates as a contract research organization (CRO) and emphasizes virtual and mobile clinical trials, machine learning, and data synthesis. Its services include investigator-led research, adaptive clinical trial design, patient recruitment, and public health strategies for U.S. federal agencies. Rubix LS has achieved significant milestones, such as integrating over 18 million patient data sets and designing more than 50 inclusive research frameworks globally. The company is also planning to establish a clinical trial site in Lawrence, MA, which will create jobs and further support underrepresented communities.